Community Gathering: Testing Solutions in Cancer

In the realm of contemporary cancer wellness, liquid biopsy has emerged as a pivotal player, reshaping the landscape of cancer screening and diagnostics. This month we are excited to welcome a great resource in blood-based diagnostics. Chad Bonfiglio will be joining us from Datar Genetics to share a presentation about non-invasive, blood-based technologies for cancer diagnosis, treatment, and remission monitoring. 

Who is Datar Cancer Genetics?

Datar Cancer Genetics is a global leader in developing blood-based diagnostics that can detect cancer early and offer non-invasive investigations for better treatment. At the forefront of this revolution are Datar's visionary scientists, who have devoted their expertise and ingenuity to craft unparalleled customized, non-invasive tests for the benefit of patients. By harnessing the power of molecular science and unraveling the mysteries held within Circulating Tumor Cells (CTCs) and DNA / RNA fragments, Datar has ushered in a new era of personalized cancer management through…